Cite
MLA Citation
Brian D. Weiss et al.. “NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.” Journal of clinical oncology, vol. 39, no. 7, 2021, pp. 797–806. http://access.bl.uk/ark:/81055/vdc_100170094473.0x000023